Potentiation of the antinociceptive effect of clomipramine by a 5‐ht1A antagonist in neuropathic pain in rats
Open Access
- 1 March 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 132 (5) , 1118-1126
- https://doi.org/10.1038/sj.bjp.0703897
Abstract
The benefit of antidepressant treatment in human neuropathic pain is now well documented, but the effect is limited and slow to appear. It has been demonstrated that the association of a 5-HT(1A) antagonist and a serotoninergic antidepressant reduced the delay of action and increases the thymoanaleptic effect of the drug. The purpose of this work was to evaluate the combination of an antidepressant and a 5-HT(1A) antagonist in animal models of chronic neuropathic pain. We studied the antinociceptive effect of the co-administration of clomipramine and a 5-HT(1A) antagonist (WAY 100,635) in a pain test applied in normal rats and in two models of neurogenic sustained pain (mononeuropathic and diabetic rats). The results show an increase in the antinociceptive effect of acutely injected clomipramine due to WAY 100,635 in these models, which is majored when the two drugs are repeatedly injected. The 5-HT(1A) antagonist reduced the delay of onset and increased the maximal antinociceptive effect of clomipramine. These new findings argue for using the combination of an antidepressant and a 5-HT(1A) antagonist in human neuropathic pain therapy.Keywords
This publication has 55 references indexed in Scilit:
- The effect of an aldose reductase inhibitor (Sorbinil®) on diabetic neuropathy and neural function of the retina: a double-blind studyActa Neurologica Scandinavica, 2009
- The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranesPublished by Elsevier ,2003
- Neuroanatomy of the Pain System and of the Pathways That Modulate PainJournal Of Clinical Neurophysiology, 1997
- Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonistsTrends in Neurosciences, 1996
- Pro- and antinociceptive actions of serotonin (5-HT)1A agonists and antagonists in rodents: relationship to algesiometric paradigmBehavioural Brain Research, 1995
- Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in micePain, 1994
- Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortexBrain Research, 1992
- The Use of Antidepressants in the Treatment of Chronic PainDrugs, 1991
- Further evidence for ‘pain-related’ behaviours in a model of unilateral peripheral mononeuropathyPain, 1990
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983